TABLE 2.
Procedural findings | PFA (N = 100)* |
No procedures performed | |
– Operator 1 | 37% (37) |
– Operator 2 | 35% (35) |
– Operator 3 | 14% (14) |
– Operator 4 | 6% (6) |
– Operator 5 | 4% (4) |
– Operator 6 | 4% (4) |
Mapping | 18% (18) |
Posterior wall isolation | 12% (12) |
– Average applications | 19.2 ± 8.7 |
Procedure time (skin to skin) [min] | |
– With mapping | 105.5 ± 25.5 |
– Without mapping | 52.3 ± 16.6 |
– Total | 60.9 ± 26.8 |
LA time [min] | 44.8 ± 23.5 |
Same day discharge | 81% (81) |
Radiation time [min] | 13.5 ± 7.5 |
Radiation dose [μGy/m2] | 658 (376–1037) |
RF touch up | 0% (0) |
Isolated PVs (isolated/total PVs) | 100% (391/391) |
Total applications | 32.3 ± 2.5 |
Average applications per PV | 8.1 ± 0.6 |
– RSPV | 8.2 ± 1.0 |
– RIPV | 8.1 ± 0.5 |
– LSPV | 8.3 ± 1.2 |
– LIPV | 8.2 ± 0.8 |
– LCO | 11.1 ± 2.7 |
PFA catheter | |
– 31 mm | 77% (77) |
– 35 mm | 23% (23) |
LA, left atrium; RF, radiofrequency; PV, pulmonary vein; RSPV, right superior PV; RIPV, right inferior PV; LSPV, left superior PV; LIPV, left inferior PV; LCO, left common ostium; PFA, pulsed field ablation.
*Data are presented as mean and standard deviation for continuous variables and median and interquartile range or number and percentages for categorical variables.